Large-scale combining signals from both biomedical literature and the FDA Adverse Event Reporting System (FAERS) to improve post-marketing drug safety signal detection

BACKGROUND: Independent data sources can be used to augment post-marketing drug safety signal detection. The vast amount of publicly available biomedical literature contains rich side effect information for drugs at all clinical stages. In this study, we present a large-scale signal boosting approac...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Rong, Wang, QuanQiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906761/
https://www.ncbi.nlm.nih.gov/pubmed/24428898
http://dx.doi.org/10.1186/1471-2105-15-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906761/
https://www.ncbi.nlm.nih.gov/pubmed/24428898
http://dx.doi.org/10.1186/1471-2105-15-17

Ejemplares similares